Celecoxib for Chemoprevention of Primary Lung Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Celecoxib (Primary)
- Indications Non-small cell lung cancer
- Focus Biomarker; Pharmacodynamics
- 03 Aug 2020 Biomarkers information updated
- 04 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Nov 2010 Actual end date (May 2009) added as reported by ClinicalTrials.gov.